BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31824830)

  • 1. Onsite healthcare worker acceptability and performance of the point-of-care Pima CD4 assay in Dar es Salaam, Tanzania.
    Schmitz ME; Chang K; Arnett N; Kohatsu L; Lemwayi R; Mwasekaga M; Nkengasong J; Bolu O; Mosha F; Westerman L
    Afr J Lab Med; 2019; 8(1):740. PubMed ID: 31824830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube.
    Kohatsu L; Bolu O; Schmitz ME; Chang K; Lemwayi R; Arnett N; Mwasekaga M; Nkengasong J; Mosha F; Westerman LE
    PLoS One; 2018; 13(8):e0202018. PubMed ID: 30138398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients.
    Wade D; Daneau G; Aboud S; Vercauteren GH; Urassa WS; Kestens L
    J Acquir Immune Defic Syndr; 2014 Aug; 66(5):e98-107. PubMed ID: 24853304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of the performance of the Pima™ CD4 for point of care testing.
    Scott LE; Campbell J; Westerman L; Kestens L; Vojnov L; Kohastsu L; Nkengasong J; Peter T; Stevens W
    BMC Med; 2015 Jul; 13():168. PubMed ID: 26208867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV Patients in the Interior of the Amazon Region, Brazil.
    Pinto IC; Sabidó M; Pereira AB; Mello MB; de Melo Xavier Shimizu A; Protti BL; Benzaken AS
    PLoS One; 2015; 10(4):e0121400. PubMed ID: 25905775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya.
    Zeh C; Rose CE; Inzaule S; Desai MA; Otieno F; Humwa F; Akoth B; Omolo P; Chen RT; Kebede Y; Samandari T
    J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of PIMA point-of-care CD4 analyzer in Yunnan, China.
    Liang J; Duan S; Ma YL; Wang JB; Su YZ; Zhang H; Ou CY; Hao L; Qi MS; Bulterys M; Westerman L; Jiang Y; Xiao Y
    Chin Med J (Engl); 2015 Apr; 128(7):890-5. PubMed ID: 25836608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of FACSPresto Point-of-Care Instrument for CD4-T Cell Enumeration in Human Immunodeficiency Virus (HIV)-Infected Patients Attending Care and Treatment Clinics in Belgium and Tanzania.
    Daneau G; Aboud S; Prat I; Urassa W; Kestens L
    PLoS One; 2017; 12(1):e0170248. PubMed ID: 28129324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Task-shifting point-of-care CD4+ testing to lay health workers in HIV care and treatment services in Namibia.
    Kaindjee-Tjituka F; Sawadogo S; Mutandi G; Maher AD; Salomo N; Mbapaha C; Neo M; Beukes A; Gweshe J; Muadinohamba A; Lowrance DW
    Afr J Lab Med; 2017; 6(1):643. PubMed ID: 29159139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisite evaluation of point of care CD4 testing in Papua New Guinea.
    Malagun M; Nano G; Chevallier C; Opina R; Sawiya G; Kivavia J; Kalinoe A; Nathaniel K; Kaminiel O; Millan J; Carmone A; Dini M; Palou T; Topma K; Lavu E; Markby J
    PLoS One; 2014; 9(11):e112173. PubMed ID: 25426710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field Performance of PIMA Point-of-Care Machine for CD4 Enumeration Under a Mobile HIV Counseling and Testing Program in Remote Fishing Communities of Lake Victoria, Uganda.
    Namuniina A; Lutwama F; Biribawa VM; Kizza D; Kabuubi BR; Kitandwe PK; Mpendo J; Nanvubya A; Ssempiira J; Nalutaaya A; Ssetaala A; Welsh S; Price MA; Kiwanuka N; Bagaya BS
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):382-387. PubMed ID: 30560683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis.
    Pham MD; Agius PA; Romero L; McGlynn P; Anderson D; Crowe SM; Luchters S
    BMC Infect Dis; 2016 Oct; 16(1):592. PubMed ID: 27769181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
    Mnyani CN; McIntyre JA; Myer L
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.
    Diaw PA; Daneau G; Coly AA; Ndiaye BP; Wade D; Camara M; Mboup S; Kestens L; Dieye TN
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):e103-11. PubMed ID: 21909029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated point-of-care testing (POCT) for HIV, syphilis, malaria and anaemia at antenatal facilities in western Kenya: a qualitative study exploring end-users' perspectives of appropriateness, acceptability and feasibility.
    Young N; Achieng F; Desai M; Phillips-Howard P; Hill J; Aol G; Bigogo G; Laserson K; Ter Kuile F; Taegtmeyer M
    BMC Health Serv Res; 2019 Jan; 19(1):74. PubMed ID: 30691447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care CD4+ technology implementation in Free State, South Africa, was associated with improved patient health outcomes.
    Van Turha L; Maharaj K; Rose A; Boeke C; Peter TF; Vojnov L; Quevedo J; Tsibolane Y
    S Afr Med J; 2020 Jan; 110(2):126-131. PubMed ID: 32657683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa.
    Glencross DK; Coetzee LM; Faal M; Masango M; Stevens WS; Venter WF; Osih R
    J Int AIDS Soc; 2012 Jan; 15(1):3. PubMed ID: 22284546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare Workers' Knowledge and Resource Availability for Care of Sickle Cell Disease in Dar es Salaam, Tanzania.
    Jonathan A; Tutuba H; Lloyd W; Ndunguru J; Makani J; Ruggajo P; Minja IK; Balandya E
    Front Genet; 2021; 12():773207. PubMed ID: 35222514
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of PIMA analyzer detecting CD4 cell count of venous and capillary blood in HIV-infected individuals].
    Su YZ; Jia MH; Jiang Y; Xiao Y; Shi YH; Chen HC; Yan WY; Yang L; Yang CJ; Chen M; Dong LJ; Ma YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Nov; 47(11):1001-5. PubMed ID: 24507227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.
    Sukapirom K; Onlamoon N; Thepthai C; Polsrila K; Tassaneetrithep B; Pattanapanyasat K
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):141-7. PubMed ID: 21709568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.